Repligen | RGEN - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
Agilent USD 364M 78M 2025-12
Align Technology USD 148.69M 193K 2026-06
Bio Techne USD 50.78M 34.21M 2025-12
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Bruker USD 68.2M 140.8M 2025-12
Charles River Laboratories USD -294.1M 464.13M 2025-12
Danaher USD 1.08B 157M 2026-06
Dentsply International USD -42M 105M 2026-03
General Electric Aerospace USD 2.2B 654M 2026-03
Henry Schein USD 150M 17M 2026-03
Illumina USD 157M 220M 2026-03
IQVIA Holdings USD 6.22B 5.68B 2026-03
Mettler Toledo International USD 209.66M 119.42M 2026-03
Myriad Genetics USD 4.6M 3.4M 2025-12
OraSure Technologies USD -18.43M 5.14M 2025-12
Pacific Biosciences Of California USD -40.17M 2.55M 2025-12
Pfizer USD 5.18B 6.82B 2026-03
Repligen USD 1.77M 17.34M 2026-03
Revvity USD 91.56M 35.88M 2025-12
Standard Biotools USD -14.62M 7.42M 2026-03
Thermo Fisher Scientific USD 1.73B 389M 2026-03
Waters USD 264.18M 94.06M 2025-12
West Pharmaceutical Services USD 180.1M 18.6M 2026-03